Terms: = Prostate cancer AND CDH1, uvomorulin, 999, P12830, ENSG00000039068, CDHE, Arc-1, UVO, LCAM, CD324, ECAD AND Diagnosis
41 results:
1. Comparative Study of Different Imaging Modalities for diagnosis of Bone Metastases of prostate cancer: A Bayesian Network Meta-analysis.
Kim K; Ha M; Kim SJ
Clin Nucl Med; 2024 Apr; 49(4):312-318. PubMed ID: 38350066
[TBL] [Abstract] [Full Text] [Related]
2. Variability of mpMRI diagnostic performance according to the upfront individual patient risk of having clinically significant prostate cancer.
Pellegrino F; Stabile A; Sorce G; Mazzone E; Cannoletta D; Cirulli GO; Quarta L; Leni R; Robesti D; Brembilla G; Gandaglia G; De Cobelli F; Montorsi F; Briganti A
Prostate; 2024 Apr; 84(5):473-478. PubMed ID: 38149793
[TBL] [Abstract] [Full Text] [Related]
3. Orthopaedic surgeons' ability to detect pathologic hip fractures: review of 1484 fractures reported to the Norwegian Hip Fracture Register.
Sund A; Dybvik E; Gjertsen JE
J Orthop Surg Res; 2023 Nov; 18(1):832. PubMed ID: 37925444
[TBL] [Abstract] [Full Text] [Related]
4. prostate cancer Disparities in Metastatic and Treatment Status for Hispanic Americans Based on Country of Origin Compared to Non-Hispanic Whites Using the National cancer Database.
Estrada-Mendizabal RJ; Dhaliwal AS; Bertolo AJ; Batai K; Heimark R; Recio-Boiles A; Chipollini J
Clin Genitourin Cancer; 2024 Feb; 22(1):e148-e155.e1. PubMed ID: 37903669
[TBL] [Abstract] [Full Text] [Related]
5. [Diagnostic efficacy of prostate cancer using targeted biopsy with 6-core systematic biopsy for patients with PI-RADS 5].
Liu Y; Yuan CW; Wu JY; Shen Q; Xiao JX; Zhao Z; Wang XY; Li XS; He ZS; Zhou LQ
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 55(5):812-817. PubMed ID: 37807733
[TBL] [Abstract] [Full Text] [Related]
6. Rosiglitazone has a null association with the risk of prostate cancer in type 2 diabetes patients.
Tseng CH
Front Endocrinol (Lausanne); 2023; 14():1185053. PubMed ID: 37560306
[TBL] [Abstract] [Full Text] [Related]
7. Variability of radiotherapy volume delineation: PSMA PET/MRI and MRI based clinical target volume and lymph node target volume for high-risk prostate cancer.
Liu LL; Zhu LL; Lu ZG; Sun JD; Zhao J; Wang HF; Xiang ZL
Cancer Imaging; 2023 Jan; 23(1):1. PubMed ID: 36600283
[TBL] [Abstract] [Full Text] [Related]
8. Radiologists' Contribution to Variation in Detecting Clinically Significant prostate cancer in Men With prostate MRI.
Naik S; Burk KS; Budiawan E; Lacson R; Lee LK; Fennessy FM; Tempany C; Cole AP; Trinh QD; Kibel AS; Khorasani R
J Am Coll Radiol; 2022 Dec; 19(12):1312-1321. PubMed ID: 36244674
[TBL] [Abstract] [Full Text] [Related]
9. Positive urine culture prior to transrectal prostate biopsy was not associated with infectious complications development.
Mrad Dali K; Rahoui M; Chaker K; Ouanes Y; Bibi M; Sellami A; Ben Rhouma S; Nouira Y
Prog Urol; 2022 Oct; 32(12):830-835. PubMed ID: 35787977
[TBL] [Abstract] [Full Text] [Related]
10. Risk of prostate cancer in relatives of prostate cancer patients in Sweden: A nationwide cohort study.
Xu X; Kharazmi E; Tian Y; Mukama T; Sundquist K; Sundquist J; Brenner H; Fallah M
PLoS Med; 2021 Jun; 18(6):e1003616. PubMed ID: 34061847
[TBL] [Abstract] [Full Text] [Related]
11. "Free-Hand" Transperineal prostate Biopsy Under Local Anesthesia: Review of the Literature.
Szabo RJ
J Endourol; 2021 Apr; 35(4):525-543. PubMed ID: 33380279
[No Abstract] [Full Text] [Related]
12. TP53 alterations of hormone-naïve prostate cancer in the Chinese population.
Liu Z; Guo H; Zhu Y; Xia Y; Cui J; Shi K; Fan Y; Shi B; Chen S
Prostate Cancer Prostatic Dis; 2021 Jun; 24(2):482-491. PubMed ID: 33214693
[TBL] [Abstract] [Full Text] [Related]
13. Does whole-body bone SPECT/CT provide additional diagnostic information over [18F]-FCH PET/CT for the detection of bone metastases in the setting of prostate cancer biochemical recurrence?
de Leiris N; Leenhardt J; Boussat B; Montemagno C; Seiller A; Phan Sy O; Roux J; Laramas M; Verry C; Iriart C; Fiard G; Long JA; Descotes JL; Vuillez JP; Riou L; Djaileb L
Cancer Imaging; 2020 Aug; 20(1):58. PubMed ID: 32787923
[TBL] [Abstract] [Full Text] [Related]
14. The deleterious association between proton pump inhibitors and prostate cancer-specific mortality - a population-based cohort study.
Goldberg H; Mohsin FK; Saskin R; Kulkarni GS; Berlin A; Kenk M; Wallis CJD; Chandrasekar T; Klaassen Z; Saarela O; Penn L; Alibhai SMH; Fleshner N
Prostate Cancer Prostatic Dis; 2020 Dec; 23(4):622-629. PubMed ID: 32641738
[TBL] [Abstract] [Full Text] [Related]
15. Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study.
Ström P; Kartasalo K; Olsson H; Solorzano L; Delahunt B; Berney DM; Bostwick DG; Evans AJ; Grignon DJ; Humphrey PA; Iczkowski KA; Kench JG; Kristiansen G; van der Kwast TH; Leite KRM; McKenney JK; Oxley J; Pan CC; Samaratunga H; Srigley JR; Takahashi H; Tsuzuki T; Varma M; Zhou M; Lindberg J; Lindskog C; Ruusuvuori P; Wählby C; Grönberg H; Rantalainen M; Egevad L; Eklund M
Lancet Oncol; 2020 Feb; 21(2):222-232. PubMed ID: 31926806
[TBL] [Abstract] [Full Text] [Related]
16. Plasmacytoid acinar adenocarcinoma of the prostate: a newly described variant of prostate cancer.
Al-Hussain T; Haffner MC; Altaweel WM; Epstein JI
Hum Pathol; 2019 Dec; 94():86-91. PubMed ID: 31698007
[TBL] [Abstract] [Full Text] [Related]
17. Impact of Timeliness of Surgical Treatment on the Outcomes of Patients with Non-metastatic Non-small Cell Lung cancer: Findings From the PLCO Trial.
Abdel-Rahman O
World J Surg; 2019 Nov; 43(11):2927-2933. PubMed ID: 31332492
[TBL] [Abstract] [Full Text] [Related]
18. Exploration of the diagnostic value and molecular mechanism of miR‑1 in prostate cancer: A study based on meta‑analyses and bioinformatics.
Xie ZC; Huang JC; Zhang LJ; Gan BL; Wen DY; Chen G; Li SH; Yan HB
Mol Med Rep; 2018 Dec; 18(6):5630-5646. PubMed ID: 30365107
[TBL] [Abstract] [Full Text] [Related]
19. Comparison of complications rates between multiparametric magnetic resonance imaging-transrectal ultrasound (TRUS) fusion and systematic TRUS prostatic biopsies.
Queiroz MRG; Falsarella PM; Mariotti GC; Lemos GC; Baroni RH; Mussi TC; Garcia RG
Abdom Radiol (NY); 2019 Feb; 44(2):732-738. PubMed ID: 30255444
[TBL] [Abstract] [Full Text] [Related]
20. prostate cancer Differentiation and Aggressiveness: Assessment With a Radiomic-Based Model vs. PI-RADS v2.
Chen T; Li M; Gu Y; Zhang Y; Yang S; Wei C; Wu J; Li X; Zhao W; Shen J
J Magn Reson Imaging; 2019 Mar; 49(3):875-884. PubMed ID: 30230108
[TBL] [Abstract] [Full Text] [Related]
[Next]
